Opinion|Videos|June 5, 2024

An Overview of Potential Treatment Adverse Effects

An expert on chronic lymphocytic leukemia discusses adverse effects encountered by patients who are receiving BTK inhibitors or venetoclax-based regimens.

Video content above is prompted by the following question(s):

  • What types of adverse effects may patients encounter with BTK inhibitor therapy? Venetoclax?
  • How are these adverse effects typically managed and how does a multidisciplinary team contribute to this process?
  • What guidance do you offer to patients to assist them in effective management of potential adverse events?

Related to this article

Image of Pancreas
Rasonque (daraxonrasib), the first approved drug to directly target RAS in pancreatic cancer, nearly doubled survival in a key trial. Two patients, a caregiver and the professionals who care for people like them explain what it means to live with the disease.
Image of of hot flashes
Hot flashes are common during and after breast and prostate cancer treatment. Here is how hormone treatments compare with the nonhormonal medicines, therapies and comfort steps that national guidelines list, and why the right choice depends on your cancer.